Rabe, L., Wenz, F., Ehmann, M., Lohr, F., Hofheinz, R., & Bürgy, D. (2022). Radiotherapy and newly approved cancer drugs: A quantitative analysis of registered protocols for drugs approved for the treatment of solid tumors. Radiotherapy and oncology, 168, . https://doi.org/10.1016/j.radonc.2022.01.025
Chicago Style (17th ed.) CitationRabe, Leonie, Frederik Wenz, Michael Ehmann, Frank Lohr, Ralf-Dieter Hofheinz, and Daniel Bürgy. "Radiotherapy and Newly Approved Cancer Drugs: A Quantitative Analysis of Registered Protocols for Drugs Approved for the Treatment of Solid Tumors." Radiotherapy and Oncology 168 (2022). https://doi.org/10.1016/j.radonc.2022.01.025.
MLA (9th ed.) CitationRabe, Leonie, et al. "Radiotherapy and Newly Approved Cancer Drugs: A Quantitative Analysis of Registered Protocols for Drugs Approved for the Treatment of Solid Tumors." Radiotherapy and Oncology, vol. 168, 2022, https://doi.org/10.1016/j.radonc.2022.01.025.